Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.85% |
| Sep 30, 2025 | 45.48% |
| Jun 30, 2025 | 48.23% |
| Mar 31, 2025 | 16.84% |
| Dec 31, 2024 | -18.48% |
| Sep 30, 2024 | 16.23% |
| Jun 30, 2024 | -17.42% |
| Mar 31, 2024 | 18.83% |
| Dec 31, 2023 | -18.20% |
| Sep 30, 2023 | -16.11% |
| Jun 30, 2023 | -20.41% |
| Mar 31, 2023 | -22.52% |
| Dec 31, 2022 | -14.87% |
| Dec 31, 2021 | 68.40% |
| Sep 30, 2020 | -28.19% |
| Jun 30, 2020 | -33.82% |
| Mar 31, 2020 | -26.67% |
| Dec 31, 2019 | 30.41% |
| Sep 30, 2019 | -20.71% |
| Jun 30, 2019 | 2.08% |